BioSpectra Welcomes New Director, Offering Direct Access to the Highest Compliance Excipients & APIs


BioSpectra recently announced the appointment of Thomas Donnelly as Director of Sales and Marketing. Mr. Donnelly will manage direct sales and business activities for BioSpectra and will serve on BioSpectra’s Leadership and Senior Management Teams. The hiring comes as BioSpectra moves into a new phase of business development, which expands its product line offerings to include the new Bio Excipient and Bio Active Grades. These ICHQ7-based products are intended for use in drug products and are available directly through BioSpectra.

“Tom brings significant sales and marketing experience to the position, but his professional leadership and interpersonal skills make him the first person to represent the BioSpectra name and entire product line,” said Richard Mutchler, President of BioSpectra. “We look forward to Tom’s contribution to our strong, existing capabilities as we increase the value we deliver to our customers through new products and innovative solutions.”

Among Mr. Donnelly’s new responsibilities will be the development and implementation of sales and business strategies to support BioSpectra’s rollout of new pharmaceutical ingredient offerings – chiefly Amino Acids, Carbohydrates, and US synthesized Life Science products. Additionally, he will spearhead a drive to not only sustain the company’s surging momentum, but also to aggressively develop additional strategic business opportunities that will advance the BioSpectra brand through products that are intentionally manufactured for the most demanding end uses.

BioSpectra is a FDA- registered, cGMP compliant, manufacturer and commercial producer of biological buffers, pharmaceutical excipients and Active Pharmaceutical ingredients. BioSpectra manufactures pH stabilizing biological buffers for the biopharmaceutical industry in its state-of-the-art Pennsylvania facilities. These biological buffers offer low UV absorptivity, minimal reactivity, stable pH and high solubility in water for use in various biological applications. Excipients offered by BioSpectra are produced in accordance with cGMP guidelines to provide the highest quality materials available to the biopharmaceutical industry. Stringent product testing of BioSpectra’s laboratory reagents ensures that its customers receive only the highest quality material for use in their various laboratory applications. For more information, visit www.biospectra.us.